Identification and functional and structural characterization of the HicA3-HicB3 toxin-antitoxin system of Yersinia pestis

Les systèmes toxine-antitoxine (STA) sont généralement constitués de deux petites protéines cytoplasmiques : une toxine stable et une antitoxine instable capable de neutraliser la toxine et de réprimer l’expression de l’opéron toxine-antitoxine. Une étude menée au laboratoire avait mis en évidence que la perte du gène hicB3 (ypo3369) de Y. pestis, codant une antitoxine solitaire putative, entraine un retard de la croissance bactérienne in vitro et une atténuation de la virulence dans un modèle murin de peste bubonique (Pradel et al., 2014). Par analyse in silico, nous avons détecté, en amont de hicB3, un petit gène non annoté candidat pour coder la toxine HicA3. La surproduction de HicA3 provoque la bactériostase chez Escherichia coli et Y. pestis et la production subséquente de HicB3 restaure la croissance. HicA3 et HicB3 constituent donc un STA fonctionnel. Cependant, la perte du STA HicA3B3 n’affecte pas la virulence de Y. pestis dans un modèle murin de peste bubonique. Nous avons ensuite purifié et caractérisé les protéines HicA3 et HicB3. La toxine HicA3 est une ribonucléase monomérique de 66 aa qui comporte un résidu histidine catalytique essentiel pour son activité. L’antitoxine HicB3 a une double fonction : elle interagit avec HicA3 pour la neutraliser et elle réprime le promoteur de l’opéron hicA3B3. Des expériences de retard sur gel et de fusions transcriptionnelles avec un gène rapporteur ont révélé que l’antitoxine HicB3 et le complexe HicA3-HicB3 se fixent sur deux opérateurs chevauchant les boîtes -10 et -35 du promoteur PhicA3. Nous avons également résolu la structure cristalline de l’antitoxine HicB3 et celle du complexe HicA3-HicB3. HicB3 est un tétramère qui comporte deux domaines de fixation à l’ADN du type ruban-hélice-hélice et deux domaines de neutralisation de la toxine.Toxin-antitoxin systems (TAS) are generally constituted by two small cytoplasmic proteins: a stable toxin and an unstable antitoxin which neutralizes the toxin and represses the expression of the toxin-antitoxin operon. In previous research, our lab found that Yersinia pestis lacking the hicB3 (ypo3369) gene, encoding a putative orphan antitoxin, has a growth defect in vitro and is attenuated for virulence in a murine model of bubonic plague (Pradel et al., 2014). In silico analysis revealed a small gene upstream of hicB3, encoding a putative toxin that we called HicA3. HicA3 overproduction generates bacteriostasis of Escherichia coli and Y. pestis, and the subsequent production of HicB3 restores cell growth. HicA3 and HicB3 thus constitute a functional TAS. However, the lack of the HicA3B3 TAS does not affect Y. pestis virulence in a murine model of bubonic plague. We then purified and characterized the HicA3 and HicB3 proteins. The HicA3 toxin is a monomeric 66-aa ribonuclease with a catalytic histidine residue required for its activity. The HicB3 antitoxin has two functions: it binds and neutralizes HicA3 and it represses the hicA3B3 operon promoter. Gel-shift assays and transcriptional reporter fusion experiments showed that both HicB3 and the HicA3-HicB3 complex bind to two operators overlapping the -10 and -35 boxes of the PhicA3 promoter. We also solved the crystal structures of the HicB3 antitoxin and the HicA3-HicB3 complex. HicB3 is a tetramer with two DNA binding domains of the ribbon-helix-helix type and two toxin neutralization domains

Identification et caractérisation fonctionnelle et structurale du système toxine-antitoxine HicA3-HicB3 de Yersinia pestis

Toxin-antitoxin systems (TAS) are generally constituted by two small cytoplasmic proteins: a stable toxin and an unstable antitoxin which neutralizes the toxin and represses the expression of the toxin-antitoxin operon. In previous research, our lab found that Yersinia pestis lacking the hicB3 (ypo3369) gene, encoding a putative orphan antitoxin, has a growth defect in vitro and is attenuated for virulence in a murine model of bubonic plague (Pradel et al., 2014). In silico analysis revealed a small gene upstream of hicB3, encoding a putative toxin that we called HicA3. HicA3 overproduction generates bacteriostasis of Escherichia coli and Y. pestis, and the subsequent production of HicB3 restores cell growth. HicA3 and HicB3 thus constitute a functional TAS. However, the lack of the HicA3B3 TAS does not affect Y. pestis virulence in a murine model of bubonic plague. We then purified and characterized the HicA3 and HicB3 proteins. The HicA3 toxin is a monomeric 66-aa ribonuclease with a catalytic histidine residue required for its activity. The HicB3 antitoxin has two functions: it binds and neutralizes HicA3 and it represses the hicA3B3 operon promoter. Gel-shift assays and transcriptional reporter fusion experiments showed that both HicB3 and the HicA3-HicB3 complex bind to two operators overlapping the -10 and -35 boxes of the PhicA3 promoter. We also solved the crystal structures of the HicB3 antitoxin and the HicA3-HicB3 complex. HicB3 is a tetramer with two DNA binding domains of the ribbon-helix-helix type and two toxin neutralization domains.Les systèmes toxine-antitoxine (STA) sont généralement constitués de deux petites protéines cytoplasmiques : une toxine stable et une antitoxine instable capable de neutraliser la toxine et de réprimer l’expression de l’opéron toxine-antitoxine. Une étude menée au laboratoire avait mis en évidence que la perte du gène hicB3 (ypo3369) de Y. pestis, codant une antitoxine solitaire putative, entraine un retard de la croissance bactérienne in vitro et une atténuation de la virulence dans un modèle murin de peste bubonique (Pradel et al., 2014). Par analyse in silico, nous avons détecté, en amont de hicB3, un petit gène non annoté candidat pour coder la toxine HicA3. La surproduction de HicA3 provoque la bactériostase chez Escherichia coli et Y. pestis et la production subséquente de HicB3 restaure la croissance. HicA3 et HicB3 constituent donc un STA fonctionnel. Cependant, la perte du STA HicA3B3 n’affecte pas la virulence de Y. pestis dans un modèle murin de peste bubonique. Nous avons ensuite purifié et caractérisé les protéines HicA3 et HicB3. La toxine HicA3 est une ribonucléase monomérique de 66 aa qui comporte un résidu histidine catalytique essentiel pour son activité. L’antitoxine HicB3 a une double fonction : elle interagit avec HicA3 pour la neutraliser et elle réprime le promoteur de l’opéron hicA3B3. Des expériences de retard sur gel et de fusions transcriptionnelles avec un gène rapporteur ont révélé que l’antitoxine HicB3 et le complexe HicA3-HicB3 se fixent sur deux opérateurs chevauchant les boîtes -10 et -35 du promoteur PhicA3. Nous avons également résolu la structure cristalline de l’antitoxine HicB3 et celle du complexe HicA3-HicB3. HicB3 est un tétramère qui comporte deux domaines de fixation à l’ADN du type ruban-hélice-hélice et deux domaines de neutralisation de la toxine

N-terminome and proteogenomic analysis of the Methylobacterium extorquens DM4 reference strain for dichloromethane utilization

International audienceMethylobacterium strains can use one-carbon compounds, such as methanol, for methylotrophic growth. In addition to methanol, a few strains also utilize dichloromethane, a major industrial chlorinated solvent pollutant. With a fully assembled and annotated genome, M. extorquens DM4 is the reference bacterium for aerobic dichloromethane degradation. The doublet N-terminal oriented proteomics (dN-TOP) strategy was applied to further improve its genome annotation and a differential proteomics approach was performed to compare M. extorquens DM4 grown either with methanol or dichloromethane as the sole source of carbon and energy. These approaches led to experimental confirmation of 259 hypothetical proteins, correction of 78 erroneous predicted start codons, discovery of 39 new proteins and annotation of 66 signal peptides, including essential enzymes involved in methylotrophic growth.SignificanceDichloromethane (methylene chloride, CH2Cl2, DCM) is one of the most widely used industrial halogenated solvents and a potential carcinogen. Microbial rehabilitation of worldwide-contaminated sites involves DCM breakdown by bacteria that are able to grow using this pollutant as their sole carbon and energy source. The most-studied methylotrophic DCM degrader is Methylobacterium extorquens strain DM4. Proteomic studies of the Methylobacterium genus have been performed previously, but genome-wide investigation of N-termini of expressed proteins has not yet been performed. Differential quantitative proteomic analysis also opens new research perspectives to better monitor and understand bacterial growth with DCM

Dissection of quantitative trait loci in the Lachancea waltii yeast species highlights major hotspots

Dissecting the genetic basis of complex trait remains a real challenge. The budding yeast Saccharomyces cerevisiae has become a model organism for studying quantitative traits, successfully increasing our knowledge in many aspects. However, the exploration of the genotype-phenotype relationship in non-model yeast species could provide a deeper insight into the genetic basis of complex traits. Here, we have studied this relationship in the Lachancea waltii species which diverged from the S. cerevisiae lineage prior to the whole-genome duplication. By performing linkage mapping analyses in this species, we identified 86 quantitative trait loci (QTL) impacting the growth in a large number of conditions. The distribution of these loci across the genome has revealed two major QTL hotspots. A first hotspot corresponds to a general growth QTL, impacting a wide range of conditions. By contrast, the second hotspot highlighted a trade-off with a disadvantageous allele for drug-free conditions which proved to be advantageous in the presence of several drugs. Finally, a comparison of the detected QTL in L. waltii with those which had been previously identified for the same trait in a closely related species, Lachancea kluyveri was performed. This analysis clearly showed the absence of shared QTL across these species. Altogether, our results represent a first step toward the exploration of the genetic architecture of quantitative trait across different yeast species

Lessons from the meiotic recombination landscape of the ZMM deficient budding yeast Lachancea waltii

Meiotic recombination has been deeply characterized in a few model species only, notably in the budding yeast Saccharomyces cerevisiae. Interestingly, most members of the ZMM pathway that implements meiotic crossover interference in S. cerevisiae have been lost in Lachancea yeast species after the divergence of Lachancea kluyveri from the rest of the clade. This suggests major differences in the control of crossover distribution. After investigating meiosis in L. kluyveri, we determined the meiotic recombination landscape of Lachancea waltii and identified several characteristics that should help understand better the underlying mechanisms. Such characteristics include systematic regions of loss of heterozygosity (LOH) in L. waltii hybrids, compatible with dysregulated Spo11-mediated DNA double strand breaks (DSB) independently of meiosis. They include a higher recombination rate in L. waltii than in L. kluyveri despite the lack of multiple ZMM pro-crossover factors. L. waltii exhibits an elevated frequency of zero-crossover bivalents as L. kluyveri but opposite to S. cerevisiae. L. waltii gene conversion tracts lengths are comparable to those observed in S. cerevisiae and shorter than in L. kluyveri despite the lack of Mlh2, a factor limiting conversion tracts size in S. cerevisiae. L. waltii recombination hotspots are not shared with either S. cerevisiae or L. kluyveri, showing that meiotic recombination hotspots can evolve at a rather limited evolutionary scale within budding yeasts. Finally, in line with the loss of several ZMM genes, we found only residual crossover interference in L. waltii likely coming from the modest interference existing between recombination precursors.Significance statement Studying non-model species is relevant to understand better biological processes by shedding light on their evolutionary variations. Here we chose the non-model budding yeast Lachancea waltii to study meiotic recombination. In sexually reproducing organisms, meiotic recombination shuffles parental genetic combinations notably by crossovers that cluster in hotspots at the population level. We found remarkable variations compared to both the canonical Saccharomyces cerevisiae model and another close relative Lachancea kluyveri. Such variations notably include the loss in L. waltii of a layer of regulation of crossover distribution that is otherwise conserved in budding yeasts and mammals. They also include the lack of conservation of crossover hotspots across the Lachancea species while crossover hotspots are remarkably stable across the Saccharomyces species

Status of ZMM proteins in <i>L</i>. <i>waltii</i> in reference to <i>S</i>. <i>cerevisiae</i> and <i>L</i>. <i>kluyveri</i>.

(XLSX)</p

Genome Sequence of the Dichloromethane-Degrading Bacterium Hyphomicrobium sp. Strain GJ21

The genome sequence of Hyphomicrobium sp. strain GJ21, isolated in the Netherlands from samples of environments contaminated with halogenated pollutants and capable of using dichloromethane as its sole carbon and energy source, was determined

Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort

International audienceThe etiopathogenesis of critical COVID-19 remains unknown. Indeed given major confounding factors (age and comorbidities), true drivers of this condition have remained elusive. Here, we employ an unprecedented multi-omics analysis, combined with artificial intelligence, in a young patient cohort where major comorbidities have been excluded at the onset. Here, we established a three-tier cohort of individuals younger than 50 years without major comorbidities. These included 47 “critical” (in the ICU under mechanical ventilation) and 25 “non-critical” (in a non-critical care ward) COVID-19 patients as well as 22 healthy individuals. The analyses included whole-genome sequencing, whole-blood RNA sequencing, plasma and blood mononuclear cells proteomics, cytokine profiling and high-throughput immunophenotyping. An ensemble of machine learning, deep learning, quantum annealing and structural causal modeling led to key findings. Critical patients were characterized by exacerbated inflammation, perturbed lymphoid/myeloid compartments, coagulation and viral cell biology. Within a unique gene signature that differentiated critical from non-critical patients, several driver genes promoted critical COVID-19 among which the upregulated metalloprotease ADAM9 was key. This gene signature was supported in a second independent cohort of 81 critical and 73 recovered COVID-19 patients, as were ADAM9 transcripts, soluble form and proteolytic activity. Ex vivo ADAM9 inhibition affected SARS-CoV-2 uptake and replication in human lung epithelial cells. In conclusion, within a young, otherwise healthy, COVID-19 cohort, we provide the landscape of biological perturbations in vivo where a unique gene signature differentiated critical from non-critical patients. The key driver, ADAM9, interfered with SARS-CoV-2 biology. A repositioning strategy for anti-ADAM9 therapeutic is feasible